Sunday, 8 July 2018

[ ::: ♥Keep_Mailing♥ ::: ]™ Going Bald? Help Might Just be Around the Corner...


There's a whole range of treatments for balding on the market. But what if you had the option of re-growing your hair simply by applying some ointment?

Kang-yeol said that "we have found a protein that controls the hair growth and developed a new substance that promotes hair regeneration by controlling the function of the protein. We expect that the newly developed substance will contribute to the development of a drug that not only treats hair loss but also regenerates damaged skin tissues."

The offender is CXXC-type zinc finger protein 5 (CXXC5), which acts as a negative regulator on the Wnt/β-catenin pathway, which is connected to hair regeneration and wound healing. When this protein binds to another protein known as the Dishevelled protein, it prevents follicle development and hair regrowth.

A new biomaterial developed by the team interferes with this binding process. It's called PTD-DBM, and when applied to the bare skin of hairless mice for 28 days, new follicles start to develop. 

A 2013 study found that, in humans, a treatment for androgenetic alopecia was much more effective when accompanied by microneedling – rolling very fine needles over the skin to puncture it.

Kang-yeol and his team got their best results by combining wound-induced hair neogenesis with PTD-PBM and valproic acid, usually used to treat bipolar, schizophrenia, migraines and seizures. In this case, it was used topically to activate the Wnt/β-catenin pathway.

Therefore, there's a threefold action. The wounds induce the generation of follicles; the valproic acid stimulates the cell pathway linked to the development of follicles; and the PTDPBD inhibits CXXC5 from interfering with the follicular development process.

However, it may be some time before this treatment becomes readily available. New treatments often take time to develop, not least because they need to go through clinical trials to ensure they're safe for humans. Nevertheless, the team's research is progressing fast. They're currently testing their new substance on other animals to determine whether it's toxic, before proceeding to human trials.

 



--
You received this message because you are subscribed to the Google Groups "Keep_Mailing" group.
To unsubscribe from this group and stop receiving emails from it, send an email to keep_mailing+unsubscribe@googlegroups.com.
To post to this group, send email to keep_mailing@googlegroups.com.
Visit this group at https://groups.google.com/group/keep_mailing.
To view this discussion on the web visit https://groups.google.com/d/msgid/keep_mailing/CAH3M5OtF2gJXx1g-phpBQyADVBb7%3DuNeWZWrmL3duCZfoprOwA%40mail.gmail.com.
For more options, visit https://groups.google.com/d/optout.

No comments:

Post a Comment